4th Quarter - Report

PORTERFIELD, FETTIG & SEARS, LLC for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 4857, Ensuring Equal Access to Treatments Act of 2014; S. 2980, Ensuring Equal Access to Treatments Act

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has advocated and listed herein.

LobbyistCovered position, as disclosed
JEREMY RABINOVITZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2980 (113th), H.R. 4857 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.